The Acute Myeloid Leukemia Channel is supported with funding from BMS (Silver), and through an educational grant from Jazz Pharmaceuticals.
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
EBMT 2016 | Drugs vs transplants in acute leukemias
Arnon Nagler, MD, from Sheba Medical Center, Tel Hashomer, Israel, discusses the use of drugs and transplantation in acute leukemias. Prof Nagler describes how drug therapy and transplantation are used together in order to achieve the best outcomes for the patients. For example, with the help of the drugs, the mass of a tumor can be reduced pre-transplant, which in turn means, that less chemotherapy may be required.
Recorded at the 2016 Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT), held in Valencia, Spain.
